Cytoplasmic sequestration and functional repression of p53 in the mammary epithelium is reversed by hormonal treatment

Cancer Research

Volumn 60, Issue 10, 2000, Pages 2723-2729

  Kuperwasser, Charlotte ^a   Pinkas, Jan ^a   Hurlbut, Gregory D ^a   Naber, Stephen P ^b   Jerry, D Joseph ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b BAYSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; PROTEIN P53; SERIC GONADOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST DUCT; BREAST EPITHELIUM; CANCER PREVENTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RADIATION CARCINOGENESIS;

ANIMALS; CHORIONIC GONADOTROPIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYTOPLASM; DNA DAMAGE; FEMALE; GENES, P53; GONADOTROPINS, EQUINE; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PLACENTAL HORMONES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034657294     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Kelsey, J. L., and Gammon, M. D. The epidemiology of breast cancer. CA Cancer J. Clin., 41: 146-165, 1991.
2. Harris, J., Lippman, M., Veronesi, U., and Willett, W. Breast cancer. N. Engl. J. Med., 327: 390-398, 1992.
3. Russo, J., and Russo, I. Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res., 40: 2677-2687, 1980.
4. Russo, J., Tay, L. K., and Russo, I. H. Differentiation of the mammary gland and susceptibility to carcinogenesis. Br. Cancer Res. Treat., 2: 5-73, 1982.
5. Russo, J., and Russo, I. H. Biological and molecular basis of mammary carcinogensis. Lab. Investig., 57: 112-137, 1987.
6. Russo, J., and Russo, I. Differentiation and breast cancer. Medicina, 57: 81-91, 1997.
7. MacMahon, B., Cole, P., and Brown, J. Etiology of human breast cancer: a review. J. Natl. Cancer Inst., 50: 21-42, 1972.
8. Sivaraman, L., Stephens, L. C., Markaverich, B. M., Clarke, J. A., Krnacik, S., Conneely, O. M., O'Malley, B., and Medina, D. Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats. Carcinogenesis (Lond.), 19: 1573-1581, 1998.
9. Srivastava, P., Russo, J., and Russo, I. Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death. Carcinogenesis (Lond.), 18: 1799-1808, 1997.
10. Hollstein, M., Rice, K., Greenblatt, M., Soussi, T., Fuchs, R., Sorlie, T., Hovig, E., Smith-Sorensen, B., Montesano, R., and Harris, C. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acid Res., 22: 3551-3555, 1994.
11. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAFI. a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
12. Kastan, M., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
13. Smith, M. L., Chen, I. T., Zhan, Q., Bae, I., Chen, C., Gilmer, T. M., and Kastan, M. B. Interaction of the p53-regulated protein GADD45 with proliferating cell nuclear antigen. Science (Washington DC), 266: 1376-1379, 1994.
14. Miyashita, T., Harigai, M., Hanada, M., and Reed, J. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res., 54: 3131-3135, 1994.
15. Malkin, D., Li, F., Strong, L., Fraumeni, J., Nelson, C., Kim, D., Kassel, J., Gryka, M., Bischoff, F., Tainsky, M., and Friend, S. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (Washington DC), 250: 1233-1238, 1990.
16. Kleihues, P., Schauble, B., zur Hausen, A., Esteve, J., and Ohagaki, H. Tumors associated with p53 germline mutations: a synopsis of 91 families. Am. J. Pathol., 150: 1-13, 1997.
17. Varley, J. M., McGown, G., Thorncroft, M., Santibanez-Koref, M. F., Kelsey, A. M., Tricker, K. J., Evans, D. G., and Birch, J. M. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res., 57: 3245-3252, 1997.
18. Coles, C., Condie, A., Chetty, U., Steel, M., Evans, J., and Prosser, J. p53 mutations in breast cancer. Cancer Res., 52: 5291-5298, 1992.
19. Moll, U., Riou, G., and Levine, A. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. Natl. Acad. Sci., 89: 7262-7266, 1992.
20. Jerry, D. J., Kuperwasser, C., Downing, S. R., Pinkas, J., He, C., Dickenson, E., Marconi, S., and Naber, S. P. Delayed involution of the mammary epithelium in Balb/c-p53 null mice. Oncogene, 17: 2305-2312, 1998.
21. 1 checkpoint after DNA damage. Mol. Cell. Biol., 16: 1126-1137, 1996.
22. Sommer, S. S., Cunningham, J., McGovern, R. M., Saitoh, S., Schroeder, J. J., Wold, L. E., and Kovach, J. S. Pattern of p53 gene mutations in breast carcinomas of women of the midwestern united states. J. Natl. Cancer Inst., 84: 246-252, 1992.
23. Schlamp, C. L., Poulsen, G. L., Nork, T. M., and Nickells, R. W. Nuclear exclusion of wild-type p53 in immortalized human retinoblastoma cells. J. Natl. Cancer Inst., 89: 1530-1536, 1997.
24. Aladjem, M. I., Spike, B. T., Rodewald, L. W., Hope, T. J., Klemm, M., Jaenisch, R., and Wahl, G. M. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr. Biol., 8: 145-155, 1998.
25. Shaulsky, G., Goldfinger, N., Tosky, M., Levine, A., and Rotter, V. Nuclear localization is essential for the activity of p53 protein. Oncogene, 6: 2055-2065, 1991.
26. Liang, S., Hong, D., and Clarke, M. F. Cooperation of a single lysine and a C-teriminal domain in the cytoplasmic sequestration of the p53 protein. J. Biol. Chem., 273: 19817-19821, 1998.
27. Liang, S., and Clarke, M. F. The nuclear import of p53 is determined by the presence of a basic domain and its relative position to the nuclear localization signal. Oncogene, 18: 2163-2166, 1999.
28. Delmolino, L., Band, H., and Band, V. Expression and stability of p53 protein in normal human mammary epithelial cells. Carcinogenesis (Lond.), 14: 827-832, 1993.
29. Takahashi, K., and Suzuki, K. DNA synthesis-associated nuclear exclusion of p53 in normal human breast epithelial cells in culture. Oncogene, 9: 183-188, 1994.
30. Stommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., and Wahl, G. M. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J., 18: 1660-1672, 1999.
31. 2/M. Mol. Cell. Biol., 16: 3884-3892, 1996.
32. Sepehrina, B., Paz, I. B., Dasgupta, G., and Momand, J. Heat shock protein 84 forms a complex with mutant p53 protein predominantly within a cytoplasmic compartment of the cell. J. Biol. Chem., 271: 15084-15090, 1996.
33. MacCullum, D., Hupp, T., Midgley, C., Stuart, D., Campbell, S., Harper, A., Walsh, F., Wright, E., Balmain, A., Lane, D., and Hall, P. The p53 response to ionising radiation in adult and developing murine tissues. Oncogene, 13: 2575-2587, 1996.
34. Midgley, C., Owens, B., Briscoe, C., Thomas, D. B., Lane, D. P., and Hall, P. A. Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J. Cell. Sci., 108: 1843-1848, 1995.
35. Komarova, E. A., Chernov, M., Franks, R., Wang, K., Armin, G., Zelnick, C., Chin, D., Bacus, S., Stark, G., and Gudkov, A. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J., 16: 1391-1499, 1997.
36. Meyn, R., Stephens, L. C., Mason, K. A., and Medina, D. Radiation-induced apoptosis in normal and pre-neoplastic mammary glands in vivo: significance of gland differentiation and p53 status. Int. J. Cancer, 65: 466-472, 1996.
37. Medina, D., Stephens, L. C., Bonilla, P. J., Hollmann, C. A., Schwahn, D., Kuperwasser, C., Jerry, D. J., Butel, J. S., and Meyn. R. E. Radiation induced tumorigenesis in preneoplastic mouse mammary glands in vivo: significance of p53 status and apoptosis. Mol. Carcinog., 22: 199-207, 1998.
38. Russo, I., Koszalka, M., and Russo, J. Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis. Carcinogenesis (Lond.), 11: 1849-1855, 1990.
39. Russo, I. H., Koszalka, M., and Russo, J. Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogensis. Br. J. Cancer, 64: 481-484, 1991.
40. Guzman, R. C., Yang, J., Rajkumar, L., Thordarson, G., Chen, X., and Nandi, S. Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc. Natl. Acad. Sci. USA, 96: 2520-2525, 1999.
41. Fowler, R. E., and Edwards, R. G. Induction of superovulation and pregnancy in mature mice by gonadotrophins. J. Endocrinol., 15: 374-384, 1957.
42. Hurd, C., Khattree, N., Dinda, S., Alban, P., and Moudgil, V. Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells. Oncogene, 15: 991-995, 1997.
43. Hurd, C., Dinda, S., Khattree, N., and Moudgil, V. K. Estrogen-dependent and independent activation of the P1 promoter of the gene in transiently transfected breast cancer cells. Oncogene, 18: 1067-1072, 1999.
44. Tao, Y.-X., Rao, L., and Rao, C. V. The presence of lutenizing hormone/human chorionic gonadotropin receptors in lactating rat mammary glands. Life Sci., 60: 1297-1303, 1997.
45. Lojun, S., Bao, S., Lei, Z. M., and Rao, C. V. Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancer. Biol. Reprod., 57: 1202-1210, 1997.
46. Srivastava, P., Russo, J., Mgbonyebi, O. P., and Russo, I. H. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells. Anticancer Res., 18: 4003-4010, 1998.
47. Venkatachalam, S., Shi, Y., Jones, S. N., Vogel, H., Bradley, A., Pinkel, D., and Donehower, L. A. Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J., 17: 4657-4667, 1998.
48. Jerry, D. J., Kittrell, F. S., Kuperwasser, C., Laucirica, R., Dickinson, E. S., Bonilla, P. J., Butel, J. S., and Medina, D. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene, 19: 1052-1058, 2000.